Back to results
US 2021/0260169 A1Published application
Telomerase reverse transcriptase-based therapies
AssigneesFundacióN Del Sector PúBlico Estatal Centro Nacional De Investigaciones OncolóGicas Carlos III (F.S., Universitat Autonoma De Barcelona
InventorsMaria Bobadilla, Ivan Formentini, Maria Antonia Blasco Marhuenda, Christian Baer, Fàtima Bosch Tubert
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length.
Claims12
-12. (canceled)
A method of treating a condition associated with a disease, the method comprising:
- administering a recombinant viral vector comprising at least a capsid and a nucleic acid comprising a coding sequence for telomerase reverse transcriptase (TERT) to a subject, wherein the condition is associated with pulmonary fibrosis.
Dependencies are inferred from the claim text.